Angus Grant - Aug 9, 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Business Development
Signature
/s/ Dov Bergwerk as attorney-in-fact for Angus Grant
Stock symbol
TEVA
Transactions as of
Aug 9, 2023
Transactions value $
$0
Form type
4
Date filed
8/10/2023, 04:05 PM
Previous filing
Aug 10, 2023
Next filing
Mar 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +51.7K $0.00 51.7K Aug 9, 2023 Ordinary Shares 51.7K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Restricted share units were granted on August 9, 2023, with 12,913 vesting on each of August 9, 2024, August 9, 2025, August 9, 2026 and August 9, 2027.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.